US President Donald Trump announced the nomination of Heidi Overton to serve as commissioner of the Food and Drug Administration, the federal agency responsible for regulating food safety, pharmaceuticals, and public health matters. The president made the announcement through his Truth Social platform, characterizing Overton as a valuable member of his administration and praising her work alongside Health and Human Services Secretary Kennedy and other officials.
Overton holds medical credentials from the University of New Mexico School of Medicine and completed a doctorate in clinical investigation at Johns Hopkins University. Prior to her role in the Trump administration, she served as chief policy officer at the America First Policy Institute, a think tank focused on advancing the administration’s policy agenda. Her nomination comes after the previous FDA commissioner, Dr. Marty Makary, departed from the position in May, leaving the leadership position vacant.
The appointment requires confirmation by the US Senate. Overton has taken positions on contentious health policy matters, including public statements regarding abortion pills, which have become a focal point for anti-abortion advocates seeking stricter regulations on access. She has also participated in Trump administration initiatives aimed at negotiating pharmaceutical pricing agreements designed to reduce medication costs for American consumers.
The Trump administration’s approach to health policy has drawn scrutiny from agency staff and scientific experts, particularly regarding efforts that some have viewed as challenging established scientific consensus on topics such as vaccination. Overton’s nomination represents another significant personnel decision shaping the administration’s direction on public health matters.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI